Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026)
Verano Holdings (VRNO) reported Other Working Capital Changes of $3.6 million for Q1 2026, down 21.44% year-over-year from $4.5 million in Q1 2025, and up 189.41% quarter-over-quarter from -$4.0 million in Q4 2025.
Verano Holdings (VRNO) Other Working Capital Changes (2021 - 2026) Analysis & Trends
Verano Holdings (VRNO) has 6 years of Other Working Capital Changes data on file, last reported at $3.6 million in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $3.6 million, down 21.44% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.3 million (down 36.7% YoY), and the FY2025 annual result was $4.3 million, up 145.59% from the prior year.
- Other Working Capital Changes improved to $3.6 million in Q1 2026 per VRNO's latest filing, from -$4.0 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $14.9 million in Q2 2024 and troughed at -$12.7 million in Q3 2024.
- A 5-year average of $1.3 million and a median of $1.2 million in 2023 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 307.92% in 2024 and fell as far as 1036.35% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $5.4 million in 2022, then soared by 141.9% to $13.0 million in 2023, then sank by 111.46% to -$1.5 million in 2024, then tumbled by 168.28% to -$4.0 million in 2025, then jumped by 189.41% to $3.6 million in 2026.
- Business Quant data shows VRNO's Other Working Capital Changes at $3.6 million in Q1 2026, -$4.0 million in Q4 2025, and $6.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Verano Holdings | - | - | 98.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.56 Mn |
| Mar 31, 2026 | 3.56 Mn |
| Dec 31, 2025 | -3.98 Mn |
| Dec 31, 2025 | -3.98 Mn |
| Sep 30, 2025 | 6.38 Mn |
| Sep 30, 2025 | 6.38 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Jun 30, 2025 | -2.66 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Mar 31, 2025 | 4.53 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Dec 31, 2024 | -1.49 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Sep 30, 2024 | -12.69 Mn |
| Jun 30, 2024 | 14.86 Mn |
| Jun 30, 2024 | 14.86 Mn |
| Mar 31, 2024 | -10.07 Mn |
| Mar 31, 2024 | -10.07 Mn |
| Dec 31, 2023 | 12.96 Mn |
| Dec 31, 2023 | 12.96 Mn |